Mailing Address
717 K St. #500, Sacramento, CA 95814
Scheduling Tel: 415-399-9769
Scheduling Fax: 415-399-9439

Education
Doctorate of Clinical Psychology, Alliant International University, Sacramento, CA, May 2009
Master Clinical Psychology, Alliant International University, Sacramento, CA, 2007
Bachelor of Arts in Critical Studies, Cinema-Television, Magna Cum Laude, University of Southern California, Los Angeles, CA, May 2005

Internship
Pre-Doctoral Psychological Internship, State Center Community College District, Fresno City College Psychological Services, Fresno, CA, June 2008 to July 2009

Residency
Post-Doctoral Psychological Resident, Kaiser Permanente, Department of Psychiatry, Fremont, CA, September 2009 to August 2010

Board Certifications & Licenses
Board of Psychology, State of California, November 2010
Qualified Medical Evaluator, State of California

Practice & Professional Positions
Licensed Clinical Psychologist, Neuropsychologist, Sacramento, CA, August 2010 to present
Experience in various medical-legal evaluations including personal injury as an expert witness, fitness for duty, retirement disability, and workers compensation. Psychologist and neuropsychologist Qualified Medical Examiner (QME) since 2015.
Clinical Professor in Psychology, North State University, March 2019 to present

Professional Affiliations
American Psychological Association (APA)
Division 5: Quantitative and Qualitative Methods
Division 20: Adult Development and Aging
Division 40: Society for Clinical Neuropsychology
Division 42: Psychologists in Independent Practice
Division 53: Society of Clinical Child and Adolescent Psychology
Division 56: Trauma Psychology

Awards
Heritage Registry of Who’s Who

Presentations (Partial List)
“Demystifying Therapy.” Presentation at Fresno City College for staff and students. 2008.
“The Mind-Body Connection.” Presentation at Fresno City College for staff and students. 2008.
“Basic Concepts of Schema Therapy.” Presentation at Fresno City College for doctoral level students. 2009.
“Special Topics in Panic Disorder.” Presentation at Kaiser Permanente, Fremont, for staff. 2010.
“Psychological Testing in Workers Compensation.” Presentation for the Assocation of Workers Compensation Professionals. 2014.
"Malingering in Worker's Compensation." Presentation for California Applicants' Attorney Assocaition. 2014.
"Psych vs. Neuropsych Evaluations in Worker's Compensation." Presentation for Association of Workers Compensation Professionals. 2015.
"Psych vs. Neuropsych Evaluations in Worker's Compensation." Presentation for Safeway Division of Worker's Compensation. 2015.
"Brain & Mind: Psych vs. Neuro-Cognitive Evaluations." Presentation for the Diablo Valley Industrial Claims Association. 2016.
“The Importance of Evaluations.” Appearance on Empire Radio Now. 2017.
"Process Testing in Neuropsychological Evaluations." Presentation for first year students at Alliant International University. 2018.
"Substance Abuse, Risk Factors, Intervention, & Prognosis." Presentation for Association of Workers Compensation Professionals. 2019.
"Psychology versus Psychiatry, Neuropsychology versus Neurology, and Complicating Factors in Workers Compensation Evaluations" Association of Workers Compensation Professionals. 2019.

Licensure
State of California

Medical-Legal Issues Evaluated
* Psychiatric Disorders including Anxiety, Depression, Panic Attacks, Personality Disorders, Post Traumatic Stress Disorder (PTSD), Stress, Substance Abuse,
* Compensable Consequence Physical – Mental Claims
* Good Faith Personnel (ROLDA) Psychiatric Claims
* Psychopharmacological Evidence Based Medical Treatment Determination
* Employment Related Issues including Discrimination, Harassment
* Competency & Sanity Evaluations
* Psychiatric Suitability for Spinal Surgery
* Psychiatric Evaluations for Predominant Cause & Substantial Cause Threshold
* Psychiatric Determination for Fitness-for-Duty, Short/Long-Term Disability, Retirement Disability,
Family Medical Leave Act (FMLA), Personal Injury IMEs
* Neuropsychological Assessment of neurocognitive dysfunction in persons with suspected cerebral dysfunction due to injury, neoplasm, toxicity, drug abuse, cerebrovascular disorders, and other trauma


Back